Carpentero, Merlyn P.
HRN: 10-04-62 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/03/2023
CO-AMOXICLAV 625MG (TAB)
09/03/2023
09/10/2023
PO
625mg
BID
Nka
Waiting Final Action